Encephalitis complicating smallpox vaccination

Archives of Neurology

Volumn 60, Issue 7, 2003, Pages 925-928

  Miravalle, Augusto ^a   Roos, Karen L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; CIDOFOVIR; CORTICOSTEROID; IMMUNOGLOBULIN; LIVE VACCINE; METHYLPREDNISOLONE; NUCLEOSIDE ANALOG; RECOMBINANT VACCINE; SMALLPOX VACCINE; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ATAXIA; CELLULAR IMMUNITY; CEREBROSPINAL FLUID ANALYSIS; COMA; CONSCIOUSNESS DISORDER; CORTICOSTEROID THERAPY; CYTOTOXIC T LYMPHOCYTE; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; ENCEPHALOMYELITIS; EPIDEMIOLOGICAL DATA; EXTRAPYRAMIDAL SYMPTOM; FEBRILE CONVULSION; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH PROGRAM; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IRRITABILITY; LETHARGY; MOOD DISORDER; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NEPHROTOXICITY; NEUROLOGIC EXAMINATION; NEUTROPENIA; PHOTOPHOBIA; PLASMAPHERESIS; POSTVACCINAL ENCEPHALITIS; PRIORITY JOURNAL; RETINITIS; REVIEW; SMALLPOX; T LYMPHOCYTE; TREMOR; VACCINIA VIRUS; VIREMIA; VIRUS REPLICATION;

ANIMALS; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; HUMANS; INCIDENCE; SMALLPOX VACCINE;

EID: 0038375848     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.7.925     Document Type: Review

References (45)

1. Kawalek A, Rudikoff D. A spotlight on smallpox. Clin Dermatol. 2002;20:376-387.
2. Retief FP, Cilliers L. The epidemic of Athens, 430-426 BC. S Afr Med J. 1998;88:50-53.
3. Perrin C, Noly V, Mourer R, Schmitt D. Preservation of cutaneous structures of Egyptian mummies: an ultrastructural study. Ann Dermatol Venereol. 1994;121:470-475.
4. Barquet N, Domingo P. Smallpox: the triumph over the most terrible of the ministers of death. Ann Intern Med. 1997;127:635-642.
5. Sessa R, Palagiano C, Scifoni MG, di Pietro M, Del Piano M. The major epidemic infections: a gift from the Old World to the New? Panminerva Med. 1999;41:78-84.
6. Palferman TG. Beethoven: medicine, music, and myths. Int J Dermatol. 1994;33:664-671.
7. Cockburn C. Disease control and prevention in the 20th century: the role of immunization. Bull World Health Organ. 1977;55:3-18.
8. Parish HJ. A History of Immunization. Edinburgh, Scotland: E & S Livingstone; 1965.
9. Lucas J. An account of uncommon symptoms succeeding the measles: with the additional remarks on the infection of measles and smallpox. London Med J. 1790;11:325-331.
10. Postinfectious demyelinating diseases. In: Johnson RT, ed. Viral Infections of the Nervous System. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1998:192-194.
11. Scott TF. Postinfectious and vaccinal encephalitis. Med Clin North Am. 1967;51:701-717.
12. Rivers TM. Viruses. JAMA. 1929;92:1147-1152.
13. Lane JM, Milliar JD, Neff JM. Smallpox and smallpox vaccination policy. Annu Rev Med. 1971;22:251-272.
14. Katz SL. The case for continuing "routine" childhood smallpox vaccination in the United States. Am J Epidemiol. 1971;93:241-244.
15. Feery BJ. Adverse reactions after smallpox vaccination. Med J Aust. 1977;2:180-183.
16. Lane JM, Ruben FL, Neff JM, Milliar JD. Complications of smallpox vaccination, 1968: national surveillance in the United States. N Engl J Med. 1969;281:1201-1208.
17. Lane JM, Ruben FL, Abrutyn E, Milliar JO. Deaths attributable to smallpox vaccination, 1959 to 1966 and 1968. JAMA. 1970;212:441-444.
18. Greenberg M. Complications of vaccination against smallpox. Am J Dis Child. 1948;76:492-502.
19. Henderson DA, Fenner F. Recent events and observations pertaining to smallpox virus destruction in 2002. Clin Infect Dis. 2001;33:1057-1059.
20. Immune responses. In: Johnson RT, ed. Viral Infections of the Nervous System. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1998:61-84.
21. Gurvich EB, Vilesova IS. Vaccinia virus in postvaccinal encephalitis. Acta Virol. 1983;27:154-159.
22. + cytotoxic T lymphocytes and interferon-γ-producing T cells after smallpox vaccination. J Infect Dis. 2002;185:1657-1659.
23. Smith GL, Symons JA, Alcami A. Immune modulation by proteins secreted from cells infected by vaccinia virus. Arch Virol Suppl. 1999;15:111-129.
24. Humlová Z, Vokurka M, Esteban M, Mlková Z. Vaccinia virus induces apoptosis of infected macrophages. J Gen Virol. 2002;83:2821-2832.
25. Tschannen R, Steck AJ, Schafer R. Mechanisms in the pathogenesis of postinfectious vaccinia virus encephalomyelitis in the mouse. Neurosci Lett. 1979;15:295-300.
26. Tschannen R, Steck AJ, Schafer R. Phosphorylation of myelin basic protein by vaccinia virus. Med Microbiol Immunol. 1980;168:103-110.
27. Steck AJ, Vandevelde M. Immunological studies in demyelinating encephalitis associated with vaccinia virus and canine distemper virus infection. Prog Brain Res. 1983;59:275-279.
28. Symons JA, Tscharke DC, Price N, Smith GL. A study of the vaccinia virus interferon-γ receptor and its contribution to virus virulence. J Gen Virol. 2002;83(pt 8):1953-1964.
29. Johnson KP, Wolinsky JS, Ginsberg AH. Immune mediated syndromes. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of Clinical Neurology. Vol 34. Amsterdam, the Netherlands: Elsevier; 1978:403-424.
30. DeVries E. Postvaccinal Perivenous Encephalitis: A Pathological Anatomical Study on the Place of Postvaccinal Perivenous Encephalitis in the Group Encephalitides [monograph]. Amsterdam, the Netherlands: Elsevier; 1960:161-164.
31. Benenson A. Possible alternatives to routine smallpox vaccination in the United States. Am J Epidemiol. 1971;93:248-252.
32. Kleiman M, Brunquell P. Acute disseminated encephalomyelitis: response to intravenous immunoglobulin. J Child Neurol. 1995;10:481-483.
33. Johnson E. Studies on smallpox and complications of smallpox vaccination. Pediatrics. 1960;26:176-189.
34. Nanning W. Prophylactic effect of antivaccinia gamma-globulin against postvaccinal encephalitis. Bull World Health Organ. 1962;27:317-324.
35. De Clercq E. Cidofovir in the therapy and short-term prophylaxis of poxvirus infections. Trends Pharmacol Sci. 2002;23:456-458.
36. Snoeck R, Holy A, Dewolf-Peeters C, Van Den Oord J, De Clercq E, Andrei G. Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures. Antimicrob Agents Chemother. 2002;46:3356-3361.
37. Smallpox eradication: temporary retention of variola virus stocks. Wkly Epidemiol Rec. 2001;76:142-145.
38. Varkey P, Poland GA, Cockerill FR 3rd, Smith TF, Hagen PT. Confronting bioterrorism: physicians on the front line. Mayo Clin Proc. 2002;77:661-672.
39. Bradbury J. Orally available cidofovir derivative active against smallpox [news]. Lancet. 2002;359:1041.
40. Goldstein JA, Neff JM, Lane JM, Koplan JP. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics. 1975;55:342-347.
41. Pasternak JF, De Vivo DC, Prensky AL. Steroid-responsive encephalomyelitis in childhood. Neurology. 1980;30:481-486.
42. Straub J, Chofflon M, Delavelle J. Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: a successful recovery. Neurology. 1997;49:1145-1147.
43. Hynson JL, Kornberg AJ, Coleman LT, et al. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001;56:1308-1312.
44. Ravin P, Hedley-Whyte ET. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: case 34-2002: a 55-year-old man with cognitive and sensorimotor findings and intracranial lesions. N Engl J Med. 2002;347:1433-1440.
45. Kanter DS, Horensky D, Sperling RA, et al. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology. 1995;45:824-827.